Literature DB >> 26903499

Frequency and aetiology of hypercalcaemia.

J D McNeilly1, R Boal2, M G Shaikh2, S F Ahmed2.   

Abstract

BACKGROUND: Hypercalcaemia is rare in children and may present with characteristic signs/symptoms or coincidentally following investigations for a variety of non-specific conditions. The aetiologies of childhood hypercalcaemia are diverse. Untreated sustained hypercalcaemia has serious clinical consequences. However there is limited data regarding the true frequency and aetiologies of childhood hypercalcaemia. AIM: To determine the frequency of severe childhood hypercalcaemia in routine clinical practice.
METHODS: The laboratory database was searched for all children (0-17 years) with severe hypercalcaemia defined as non-adjusted ≥2.90 mmol/L from 2007-2012. Hypercalcaemia was categorised as either transient (1 day) or sustained (≥2 consecutive days). Retrospective analysis of all cases of sustained severe hypercalcaemia was performed to identify the underlying aetiology.
RESULTS: Over the 5 year period, 206 children were identified as severely hypercalcaemic ≥2.90 mmol/L (0.3% all 61,380 calcium requests). Of these 131 (63.3%) children were classified as having sustained hypercalcaemia. The frequency of severe hypercalcaemia was highest in neonates (42% of sustained cases) and was inversely related to age. Sepsis was the most common aetiology (24%), particularly in neonates where it accounted for 41% of all causes of neonatal hypercalcaemia. Endocrine aetiologies included congenital adrenal hyperplasia (2 cases), fat necrosis (1), Addison's disease (2). A genetic cause was identified in 3 children (2 familial hypocalciuria hypercalcaemia, 1 Williams syndrome).
CONCLUSIONS: Sustained hypercalcaemia affects 1 in 500 children in a general hospital setting. The frequency was highest in neonates and underlying aetiology differed markedly with age. All children with sustained hypercalcaemia require thorough investigation to determine the underlying aetiology to ensure appropriate management. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Biochemistry; Bone Metabolism; Endocrinology

Mesh:

Substances:

Year:  2016        PMID: 26903499     DOI: 10.1136/archdischild-2015-309029

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Childhood Sustained Hypercalcemia: A Diagnostic Challenge.

Authors:  Nisa Eda Çullas İlarslan; Zeynep Şıklar; Merih Berberoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-04-26

2.  Infants With Congenital Adrenal Hyperplasia Are at Risk for Hypercalcemia, Hypercalciuria, and Nephrocalcinosis.

Authors:  Melissa J Schoelwer; Vidhya Viswanathan; Amy Wilson; Corina Nailescu; Erik A Imel
Journal:  J Endocr Soc       Date:  2017-08-01

3.  Infantile Nephrocalcinosis Resulting From a Pathogenic CYP24A1 Mutation.

Authors:  Joel D Murphy; Mark Joseph; Christopher P Larsen
Journal:  Kidney Int Rep       Date:  2019-04-29

4.  Hypercalcemia and Neurological Symptoms: A Rare Presentation of Hyperfunctioning Parathyroid Adenoma in an Adolescent.

Authors:  Valeria Calcaterra; Gloria Pelizzo; Andreana Pipolo; Giulio Montecamozzo; Valentina Fabiano; Roberta Grazi; Patrizia Carlucci; Gianvincenzo Zuccotti
Journal:  Front Surg       Date:  2022-05-19

Review 5.  Hypercalcemic Disorders in Children.

Authors:  Victoria J Stokes; Morten F Nielsen; Fadil M Hannan; Rajesh V Thakker
Journal:  J Bone Miner Res       Date:  2017-11-02       Impact factor: 6.741

6.  Severe hypercalcemia associated with hypophosphatemia in very premature infants: a case report.

Authors:  Nicola Improda; Francesca Mazzeo; Alessandro Rossi; Claudia Rossi; Francesco Paolo Improda; Angelo Izzo
Journal:  Ital J Pediatr       Date:  2021-07-07       Impact factor: 2.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.